A Health-Related Quality of Life Measure for Patients Who Undergo Minimally Invasive Glaucoma Surgery
-
Published:2024-10
Issue:
Volume:266
Page:313-320
-
ISSN:0002-9394
-
Container-title:American Journal of Ophthalmology
-
language:en
-
Short-container-title:American Journal of Ophthalmology
Author:
Hays Ron D.ORCID, Tarver Michelle E., Eydelman Malvina, Spaeth George L., Parke David W., Singh Kuldev, Nguyen Don, Saltzmann Robert M., Smith Oluwatosin, Shaw My Le, Rosenberg Lisa, Seibold Leo, Teymoorian Savak, Provencher Lorraine M., Bicket Amanda K., Arora Nitika, Junk Anna K., Chaya Craig, Salim Sarwat, Kuo Debbie, Weiner Asher, Zhang Ze, Rhee Brian Francis Douglas, McMillan Brian, Choo Clara, Garris Winston, Noecker Rob, Fellman Ronald, Caprioli Joseph, Vold Steven, Pasquale Louis, Cui Qi, Mbagwu Michael
Funder
US Food and Drug Administration
Reference23 articles.
1. The number of people with glaucoma worldwide in 2010 and 2020;Quigley;Br J Ophthalmol,2006 2. Special commentary: supporting innovation for safe and effective minimally invasive glaucoma surgery: summary of a joint meeting of the American Glaucoma Society and the Food and Drug Administration, Washington, DC, February 26, 2014;Caprioli;Ophthalmology,2015 3. Center for Devices and Radiological Health, U.S. Food and Drug Administration. Glaukos iStent Trabecular Micro-Bypass Stent (Model: GTS-100R, GTS-100L) and Inserter (GTS-100i)—P090030, June 25 2012. Accessed May 1, 2024. www.accessdata.fda.gov/cdrh_docs/pdf8/P080030a.pdf. 4. From the patient's point of view, how should minimally invasive glaucoma surgeries be evaluated?;Cui;Am J Ophthalmol,2016 5. Health-related quality of life measurement in public health;Kaplan;Annu Rev Public Health,2022
|
|